InvestorsHub Logo
Followers 8
Posts 328
Boards Moderated 0
Alias Born 01/11/2014

Re: invst2010 post# 3262

Wednesday, 02/05/2014 11:41:23 PM

Wednesday, February 05, 2014 11:41:23 PM

Post# of 34624
You should read about why TPIV has a superior vaccine to Other approaches for HER2-neu. Glynn Wilson explains it well on the Tapimmune website. If Galena is valued at $438 million, Tapimmune will be valued at double that value when we get to Phase 3 testing.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News